Health Catalyst CFO sells 17,973 shares for taxes

Health Catalyst’s CFO executed a mandated sell-to-cover transaction for RSU tax withholding, leaving a substantial direct shareholding.

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) reported that Chief Financial Officer Jason Alger had 17,973 shares of common stock disposed of on September 1, 2026 to cover tax withholding obligations tied to vesting Restricted Stock Units. The transaction, at $1.7036 per share, was a mandated sell-to-cover and not a discretionary trade, leaving him with 704,867 shares held directly.

Insider Trade Summary

Tax Withholding: 17,973 shares

Tax Withholding 1 txn

Insider Alger Jason

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	17,973	$1.7036	$31K

Holdings After Transaction: Common Stock — 704,867 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Key Figures

Shares disposed for tax withholding: 17,973 shares Per-share value in transaction: $1.7036 per share Shares held after transaction: 704,867 shares

3 metrics

Shares disposed for tax withholding 17,973 shares Common stock delivered in a tax-withholding transaction on September 1, 2026

Per-share value in transaction $1.7036 per share Value assigned to shares used to cover RSU-related tax withholding

Shares held after transaction 704,867 shares Direct ownership by CFO Jason Alger following the September 1, 2026 transaction

Key Terms

Restricted Stock Units, sell to cover, tax withholding obligations

3 terms

Restricted Stock Units financial

"in connection with the vesting of Issuer's Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"funded by a "sell to cover" transaction and does not represent"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

tax withholding obligations financial

"to cover tax withholding obligations in connection with the vesting"

FAQ

What insider transaction did HCAT’s CFO report on this Form 4?

Health Catalyst’s CFO, Jason Alger, reported a disposition of 17,973 shares of common stock on September 1, 2026 to satisfy tax withholding obligations from vesting Restricted Stock Units through a mandated sell-to-cover transaction.

Was the HCAT CFO’s September 1, 2026 trade a discretionary sale?

No. The filing states the shares were sold to cover tax withholding obligations in connection with RSU vesting and that this sale was mandated under Health Catalyst’s equity incentive plans, so it does not represent a discretionary trade by the CFO.

How many HCAT shares does the CFO hold after this transaction?

After the September 1, 2026 tax-withholding transaction, Chief Financial Officer Jason Alger held 704,867 shares of Health Catalyst common stock directly, as reported in the Form 4 filing.

At what price were the HCAT shares used for tax withholding valued?

The 17,973 Health Catalyst shares used to cover RSU-related tax withholding were valued at $1.7036 per share, according to the Form 4 transaction details.

Was the HCAT CFO’s transaction under a Rule 10b5-1 trading plan?

No. The Rule 10b5-1 checkbox in the Form 4 is not marked as being under a plan, and the footnote describes the sale as mandated by the company’s equity incentive plans for tax withholding, not as part of a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:37 PM Accepted by SEC EDGAR 09/03/2026 - 05:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alger Jason

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		F		17,973(1)	D	$1.7036	704,867	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)